Insider · CIK 0001951291

Tanimoto Sarina

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001951291

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	CHIEF MEDICAL OFFICER, 10% Owner	AAward	+240K sh	—	—	240,000
2026-01-02	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER, 10% Owner	AAward	+875K sh	—	—	875,000
2025-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−37.7K sh	$14.09	−$531K	1,247,447
2025-08-19	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−12.3K sh	$14.03	−$173K	1,285,103
2025-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	CHIEF MEDICAL OFFICER, 10% Owner	AAward	+262K sh	—	—	261,900
2025-01-02	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	CHIEF MEDICAL OFFICER, 10% Owner	AAward	+768K sh	—	—	767,600
2024-12-17	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$11.67	−$584K	1,297,447
2024-12-17	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$11.67	−$584K	1,098,499
2024-12-10	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$13.17	−$658K	1,246,494
2024-12-10	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$13.16	−$658K	1,148,499
2024-12-06	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER, 10% Owner	MExercise/Conversion	+13.8K sh	$1.44	+$19.9K	3,421,636
2024-12-06	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER, 10% Owner	MExercise/Conversion	+11.9K sh	$8.42	+$100K	3,433,512
2024-12-06	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER, 10% Owner	MExercise/Conversion	+11.9K sh	$8.42	+$100K	4,327,189
2024-12-06	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER, 10% Owner	MExercise/Conversion	−13.8K sh	—	—	20,684
2024-12-06	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER, 10% Owner	MExercise/Conversion	−11.9K sh	—	—	338,124
2024-12-06	SPRYARS Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	CHIEF MEDICAL OFFICER, 10% Owner	MExercise/Conversion	−11.9K sh	—	—	1,088,124
2024-11-19	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$13.95	−$698K	1,347,447
2024-11-19	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$13.95	−$697K	1,198,499
2024-11-12	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−45K sh	$16.76	−$755K	1,301,449
2024-11-12	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−4,955 sh	$17.64	−$87.4K	1,296,494
2024-11-12	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−45.1K sh	$16.76	−$756K	1,253,375
2024-11-12	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−4,876 sh	$17.64	−$86K	1,248,499
2024-10-15	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−48.6K sh	$14.86	−$722K	1,398,897
2024-10-15	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−1,450 sh	$15.25	−$22.1K	1,397,447
2024-10-15	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$14.88	−$744K	1,298,499
2024-10-08	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$13.83	−$691K	1,346,494
2024-10-08	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$13.83	−$691K	1,348,499
2024-09-17	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$12.93	−$647K	1,447,447
2024-09-17	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$12.93	−$647K	1,398,499
2024-09-10	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$11.50	−$575K	1,396,494
2024-09-10	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$11.50	−$575K	1,448,499
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−35.9K sh	$14.76	−$530K	1,511,503
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−11.8K sh	$15.61	−$184K	1,499,747
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−2,300 sh	$16.26	−$37.4K	1,497,447
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−36.2K sh	$14.76	−$534K	1,512,283
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−11.5K sh	$15.62	−$180K	1,500,760
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−2,261 sh	$16.25	−$36.7K	1,498,499
2024-08-13	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−14.6K sh	$11.78	−$172K	1,481,895
2024-08-13	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−35.4K sh	$12.76	−$452K	1,446,494
2024-08-13	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−14.6K sh	$11.77	−$172K	1,583,862
2024-08-13	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−35.4K sh	$12.77	−$451K	1,548,499
2024-07-16	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$11.40	−$570K	1,547,447
2024-07-16	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$11.40	−$570K	1,598,499
2024-07-09	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$9.62	−$481K	1,496,494
2024-07-09	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−50K sh	$9.62	−$481K	1,648,499
2024-06-12	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−47.8K sh	$9.15	−$437K	1,546,494
2024-06-12	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−48K sh	$9.14	−$439K	1,698,499
2024-06-11	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−2,166 sh	$9.00	−$19.5K	1,594,328
2024-06-11	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−1,972 sh	$9.00	−$17.8K	1,746,527
2024-05-16	SPRYARS Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER, 10% Owner	SSale	−44.7K sh	$9.06	−$405K	1,597,447

Recent filings

Accepted (ET)
Jan 54
Tanimoto Sarina0001951291-26-000002
SEC(opens sec.gov)
Aug 214
Tanimoto Sarina0001415889-25-022638
SEC(opens sec.gov)
Jan 34
Tanimoto Sarina0001415889-25-000466
SEC(opens sec.gov)
Dec 194
Tanimoto Sarina0001415889-24-029852
SEC(opens sec.gov)
Dec 114
Tanimoto Sarina0001415889-24-029012
SEC(opens sec.gov)
Dec 94
Tanimoto Sarina0001415889-24-028692
SEC(opens sec.gov)
Nov 214
Tanimoto Sarina0001415889-24-027410
SEC(opens sec.gov)
Nov 144
Tanimoto Sarina0001415889-24-026867
SEC(opens sec.gov)

Companies

ARS Pharmaceuticals, Inc.CHIEF MEDICAL OFFICER, 10% OwnerSPRY

Address

C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130